Luyan Pharma Co (SZSE:002788) Interest Expense : ¥-223 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Luyan Pharma Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Luyan Pharma Co's interest expense for the three months ended in Mar. 2024 was ¥ -51 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-223 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Luyan Pharma Co's Operating Income for the three months ended in Mar. 2024 was ¥ 175 Mil. Luyan Pharma Co's Interest Expense for the three months ended in Mar. 2024 was ¥ -51 Mil. Luyan Pharma Co's Interest Coverage for the quarter that ended in Mar. 2024 was 3.44. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Luyan Pharma Co Interest Expense Historical Data

The historical data trend for Luyan Pharma Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luyan Pharma Co Interest Expense Chart

Luyan Pharma Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-149.71

-163.86

-184.06

-219.10

-222.85

Luyan Pharma Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-51.02	-57.42	-42.56	-71.86	-50.78

Luyan Pharma Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-223 Mil.

Luyan Pharma Co (SZSE:002788) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Luyan Pharma Co's Interest Expense for the three months ended in Mar. 2024 was ¥-51 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥175 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥665 Mil.

Luyan Pharma Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	174.664	/	-50.776
	=	3.44

The higher the ratio, the stronger the company's financial strength is.

Warning Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Luyan Pharma Co Ltd interest coverage is 3.24, which is low.

Luyan Pharma Co (SZSE:002788) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Luyan Pharma Co Ltd (SZSE:002788) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

1004 Ridge Road, Huli District, Fujian Province, Xiamen City, CHN, 361 010

Website

http://www.luyan.com.cn

Luyan Pharma Co Ltd, formerly Luyan (Fujian) Pharma Co Ltd engages in the production, operation, distribution, and retail of human health products in China. It provides medical and health products.

Executives

Zhu Ming Guo	Executives
Yang Cong Jin	Directors, executives
Lei Ming	Directors, executives
Li Wei Yang	Executives
Cai Mei Zhen	Supervisors
Li Cui Ping	Supervisors
Wu Jin Xiang	Directors, executives
Zhang Jun Ying	Executives
Wu Huo Lu	Director

Luyan Pharma Co (SZSE:002788) Headlines

No Headlines